Clinical trial
Rofecoxib After Surgery in Treating Patients With Stage II or Stage III…
NCT00031863 · Cancer Research Campaign Clinical Trials Centre, Other · Completed
Key facts
| NCT number | NCT00031863 |
|---|---|
| Title | Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer |
| Official title | Phase III, Randomized, Double Blind, Placebo Controlled Study of Rofecoxib in Colorectal Cancer Patients Following Adjuvant Chemotherapy |
| Lead sponsor | Cancer Research Campaign Clinical Trials Centre, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | rofecoxib, adjuvant therapy |
| Start date | Feb 1, 2001 |
| Completion | Sep 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 2, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: